Protein Fluorescent Nanoparticles via Crosslinking for Biocompatible Imaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current quantum dots used for biological applications are toxic, limiting their widespread use, and alternative materials like gold or silica require biocompatible coatings, making their synthesis complex and costly.

Innovation Solution

Development of protein fluorescent nanoparticles synthesized through crosslinking ordinary proteins with a crosslinking agent, either before or after labeling with fluorescent dyes, to create non-toxic, biocompatible, and biodegradable particles for biological imaging.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If quantum dots are used for biological applications, then fluorescent imaging capability is achieved, but toxicity increases limiting widespread use

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces toxic, stable quantum dots with biodegradable protein nanoparticles that can be safely eliminated by biological systems. The protein-based particles are designed to be transient and non-toxic, allowing repeated imaging without cumulative toxicity concerns.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent creates composite protein nanoparticles incorporating fluorescent dyes within a protein matrix. This composite structure combines the biocompatibility of proteins with the fluorescent imaging capabilities of dye molecules, achieving both safety and functionality.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If gold or silica nanoparticles are used as alternatives, then toxicity is reduced, but manufacturing complexity increases due to required biocompatible coatings

Engineering Contradiction:
ImprovetoxicityVSAvoidsynthesis complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the complex coating requirement by using proteins as the core material itself. Instead of requiring separate coating steps to achieve biocompatibility, the protein nanoparticles are inherently biocompatible, removing an entire process step.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses ordinary edible proteins that serve multiple functions: they provide biocompatibility, structural integrity, and can be easily functionalized with fluorescent dyes. This universal approach eliminates the need for specialized coating materials and processes.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Adaptability or versatility

If protein nanoparticles are synthesized with fluorescent labeling, then imaging capability is achieved, but synthesis flexibility is improved allowing labeling before or after crosslinking

Engineering Contradiction:
Improvesynthesis flexibilityVSAvoidsynthesis simplicity
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent introduces dynamic flexibility in the synthesis process by allowing fluorescent labeling at different stages (before or after crosslinking). This dynamic approach enables optimization based on specific application requirements without compromising the overall simplicity of the method.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method produces stable, biocompatible, and biodegradable protein nanoparticles with tunable fluorescent properties, enabling efficient cellular imaging and sensing across various pH and temperature ranges, while being cost-effective and simple to scale up.

Implementation Method 1

crosslinking the protein with a crosslinking agent, to thereby form the protein fluorescent nanoparticle

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 2

labeling a protein with a fluorescent dye reagent

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS10254287B2Protein fluorescent nanoparticles and methods of synthesis thereof
Publication Date: 2019.04.09 UNIV OF CONNECTICUT
  • US10254287B2 patent drawing
  • US10254287B2 patent drawing
  • US10254287B2 patent drawing

AI summary

Disclosed herein are stable and versatile protein nanoparticles having a range of tunable fluorescent properties. Such nanoparticles may find utility in biological imaging. Methods of synthesis of such nanoparticles are also disclosed.